Wang H. et al. Factors associated with clinical outcome in 25 patients with avian influenza A (H7N9) infection in Guangzhou, China. BMC Infect Dis. 2016 Oct 3;16(1):534
Abstract
Background: Guangzhou reported its first laboratory-confirmed case of influenza A (H7N9) on January 10, 2014. A
total of 25 cases were reported from the first wave of the epidemic until April 8, 2014. The fatality rate was much
higher than in previous reports. The objective of the current work was to describe the clinical and epidemiological
characteristics of A (H7N9) patients in Guangzhou and explore possible reasons for the high fatality rate.
Methods: Clinical and epidemiological information regarding A (H7N9) cases in Guangzhou was collected through
review of medical records and field research. Data regarding clinical and laboratory features, treatment, and outcomes
were extracted.
Results: Of the 25 patients, 84 % (21/25) had one or more underlying diseases. Fifteen patients (60.0 %) developed
moderate to severe acute respiratory distress syndrome (ARDS), and 14 (56 %) died of the ARDS or multiorgan failure.
Patients with longer delay between onset of illness and initiation of oseltamivir treatment were more likely to develop
ARDS. Elevated C-creative protein, aspartate aminotransferase, creatine kinase, and lymphocytopenia predicted a higher
risk of developing ARDS.
Conclusions: The presence of underlying diseases and clinical complications predicted poor clinical outcome. Early
oseltamivir treatment was associated with a reduced risk of developing ARDS.
Background: Guangzhou reported its first laboratory-confirmed case of influenza A (H7N9) on January 10, 2014. A
total of 25 cases were reported from the first wave of the epidemic until April 8, 2014. The fatality rate was much
higher than in previous reports. The objective of the current work was to describe the clinical and epidemiological
characteristics of A (H7N9) patients in Guangzhou and explore possible reasons for the high fatality rate.
Methods: Clinical and epidemiological information regarding A (H7N9) cases in Guangzhou was collected through
review of medical records and field research. Data regarding clinical and laboratory features, treatment, and outcomes
were extracted.
Results: Of the 25 patients, 84 % (21/25) had one or more underlying diseases. Fifteen patients (60.0 %) developed
moderate to severe acute respiratory distress syndrome (ARDS), and 14 (56 %) died of the ARDS or multiorgan failure.
Patients with longer delay between onset of illness and initiation of oseltamivir treatment were more likely to develop
ARDS. Elevated C-creative protein, aspartate aminotransferase, creatine kinase, and lymphocytopenia predicted a higher
risk of developing ARDS.
Conclusions: The presence of underlying diseases and clinical complications predicted poor clinical outcome. Early
oseltamivir treatment was associated with a reduced risk of developing ARDS.
See Also:
Latest articles in those days:
- Generation of Nasal Cell-Derived Human Alveolar Organoids and Organoid-Macrophage Assembloids for in Vitro Lung Modeling 11 hours ago
- Determinants of the Seasonal Influenza Vaccination Uptake Among People Aged 50 Years or Above During and After the Pandemic: A Systematic Review 24 hours ago
- [preprint]A GIS-based framework for standardized environmental characterization in One-Health surveillance: a case study of HPAI monitoring in wetlands 24 hours ago
- First detection and transatlantic introduction of Influenza A(H3N2) subclade K (J.2.4.1) into Ecuador: insights from genomic sentinel surveillance 1 days ago
- Assessment of influenza virus and coronavirus tropism, replication competence and disease severity in ex vivo and in vitro cultures of the human respiratory tract 2 days ago
[Go Top] [Close Window]
